Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Margetuximab Biosimilar – Anti-ERBB2, EGFR2, CD340 mAb – Research Grade

Isotype:
IgG1, kappa

120.00

+ 120 loyalty points
Size
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery

Margetuximab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade

Product name Margetuximab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade
Source CAS 1350624-75-7
Species Chimeric
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Margetuximab,MGAH-22,ERBB2, EGFR2, CD340,anti-ERBB2, EGFR2, CD340
Reference PX-TA1331
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody
Product name Margetuximab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade
Source CAS 1350624-75-7
Species Chimeric
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Margetuximab,MGAH-22,ERBB2, EGFR2, CD340,anti-ERBB2, EGFR2, CD340
Reference PX-TA1331
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody

General information on Anti-ERBB2/EGFR2/CD340[Homo sapiens] (Margetuximab) Monoclonal Antibody

Margetuximab is an Fc-engineered human/mouse chimeric anti-HER2 monoclonal antibody of isotype IgG1 kappa . Margetuximab targets the same epitope on the HER2 extracellular domain and hass the same activity as trastuzumab. However, margetuximab has a higher affinity for both CD16A variants and a weaker one to the inhibitory CD32B Fc receptor, thereby resulting in more efficient antibody-dependent cell-mediated cytotoxicity (ADCC) and higher efficacy compared to trastuzumab. Margetuximab has been marketed under the trade name Margenza.

There are no reviews yet.

Be the first to review “Margetuximab Biosimilar – Anti-ERBB2, EGFR2, CD340 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products